MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Anteile 2011-2026 | VIVO
Anteile Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.6 M | 43.3 M | 42.9 M | 42.6 M | 42.3 M | 42.2 M | 42 M | 41.7 M | 41.5 M | 41.2 M | 41.1 M | 40.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 43.6 M | 40.7 M | 42.1 M |
Anteile Vierteljährlich Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.9 M | 43.8 M | - | 43.5 M | 43.4 M | 43.4 M | 43.3 M | 43.2 M | 43.1 M | 42.8 M | 42.8 M | 43.1 M | 42.8 M | 42.5 M | 42.6 M | 42.8 M | 42.4 M | 42.3 M | 42.3 M | 42.4 M | 42.3 M | 42.2 M | 42.2 M | 42.3 M | 42.2 M | 42 M | 42.1 M | 42.2 M | 41.9 M | 41.6 M | 41.7 M | 41.9 M | 41.6 M | 41.4 M | 41.5 M | 41.6 M | 41.4 M | 41.2 M | 41.3 M | 41.4 M | 41.1 M | 41.1 M | 41.1 M | 41.1 M | 41.1 M | 40.7 M | 40.7 M | 41.1 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 43.9 M | 40.7 M | 42.1 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
29 M | $ 19.24 | -22.26 % | $ 558 M |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.58 | -2.53 % | $ 181 M |  China |
 |
Agilent Technologies
A
|
304 M | $ 118.65 | 0.74 % | $ 36.1 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 428.71 | 0.45 % | $ 12.4 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.09 | -0.49 % | $ 379 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 9.07 | 2.02 % | $ 1.16 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
National Research Corporation
NRC
|
22.4 M | $ 18.73 | 4.87 % | $ 419 M | USA |
 |
Natera
NTRA
|
98.4 M | $ 219.82 | 2.2 % | $ 21.6 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 27.16 | -0.26 % | $ 25.8 B |  Niderland |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Personalis
PSNL
|
59.3 M | $ 5.99 | -1.32 % | $ 355 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 21.44 | 2.39 % | $ 1.14 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.95 | 0.02 % | $ 2.69 B | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.93 | 17.68 % | $ 2.57 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
359 M | $ 0.59 | -1.99 % | $ 212 M |  Irlanda |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 181.68 | -0.03 % | $ 9 B | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 58.54 | -1.66 % | $ 3.5 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.11 | 1.27 % | $ 457 M | USA |
 |
Guardant Health
GH
|
125 M | $ 92.26 | 0.01 % | $ 11.6 B | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 125.0 | 0.7 % | $ 10.3 B | Irlanda |
 |
Illumina
ILMN
|
159 M | $ 138.71 | -2.71 % | $ 22.1 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 5.36 | - | $ 224 M | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.0 | -5.22 % | $ 8.85 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.3 M | $ 2.19 | -0.68 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 474.46 | 0.32 % | $ 179 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 91.0 | 5.63 % | $ 6.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 258.05 | 0.43 % | $ 21.5 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 130.71 | -6.26 % | $ 6.11 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.25 | 0.76 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 190.84 | 0.9 % | $ 21.2 B | USA |
 |
Waters Corporation
WAT
|
59.5 M | $ 350.49 | 0.27 % | $ 20.9 B | USA |